A Depression and Opioid Pragmatic Trial in Pharmacogenetics (ADOPT PGx) - Depression Arm

T
Todd Skaar

Primary Investigator

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (ADOPT PGx) - Depression Arm

Overview

Antidepressants are medicines that relieve symptoms of depression. Did you know that a person’s DNA can affect how well some antidepressants work? The goal of this study is to better manage your depression.

Description

Participants will complete surveys online or via phone at enrollment, 1 month, 3 months, and 6 months after enrollment. Participants will receive their genetic results after completing the final survey, as well as $25 for each completed survey at enrollment, 3 months, and 6 months.
 
Who is Eligible?
  • Individuals at least 8 years of age, 
  •  With a diagnosis of depression with at least 3 months of symptoms, 
  • Anticipated need for revised or new medication for depression, and
  • Seen within IU Health and/or Eskenazi Health system.
 
How to Participate
**If you have questions about this study or would like more information, please reach out to the study team directly at adopt1@iupui.edu or (317) 278-4400

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Depression,treatment,Depression,antidepressants,antidepressant,Depression,antidepressants,antidepressant,Depression,antidepressants,antidepressant,Depression,antidepressants,antidepressant
  • Age: Between 8 Years - 100 Years
  • Gender: All

Additional Information:


Updated on 13 Nov 2023. Study ID: 2009028572 - Depression

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center